Literature DB >> 19576178

Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer.

Wenjie Dong1, Shuiping Tu, Jing Xie, Pinghu Sun, Yunlin Wu, Lifu Wang.   

Abstract

The BTG4 gene belongs to the BTG family of genes endowed with antiproliferative properties. In this study, we have found that BTG4 undergoes promoter CpG island hypermethylation-associated inactivation in gastric cancer and 5'-aza-2'-deoxycytidine (DAC) treatment restores BTG4 expression. We also found BTG4 levels were significantly reduced in primary gastric cancer but not in normal gastric tissues. BTG4 reexpression in gastric cancer causes growth inhibition of colony assays and nude mice. Taken together, our data support BTG4 as a candidate tumor suppressor gene that is epigenetically silenced in the majority of gastric cancers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19576178     DOI: 10.1016/j.bbrc.2009.06.140

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.

Authors:  Yuriko Mori; Alexandru V Olaru; Yulan Cheng; Rachana Agarwal; Jian Yang; Delgermaa Luvsanjav; Wayne Yu; Florin M Selaru; Susan Hutfless; Mark Lazarev; John H Kwon; Steven R Brant; Michael R Marohn; David F Hutcheon; Mark D Duncan; Ajay Goel; Stephen J Meltzer
Journal:  Endocr Relat Cancer       Date:  2011-07-04       Impact factor: 5.678

2.  Down-regulation of BTG3 promotes cell proliferation, migration and invasion and predicts survival in gastric cancer.

Authors:  X L Ren; X H Zhu; X M Li; Y L Li; J M Wang; P X Wu; Z B Lv; W H Ma; W T Liao; W Wang; Y Q Ding; L Liang
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-20       Impact factor: 4.553

Review 3.  Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.

Authors:  Jun Nakamura; Tomokazu Tanaka; Yoshihiko Kitajima; Hirokazu Noshiro; Kohji Miyazaki
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Radiolabeling and evaluation of (64)Cu-DOTA-F56 peptide targeting vascular endothelial growth factor receptor 1 in the molecular imaging of gastric cancer.

Authors:  Hua Zhu; Chuanke Zhao; Fei Liu; Lixin Wang; Junnan Feng; Zheng Zhou; Like Qu; Chengchao Shou; Zhi Yang
Journal:  Am J Cancer Res       Date:  2015-10-15       Impact factor: 6.166

Review 5.  Recent progress in the study of methylated tumor suppressor genes in gastric cancer.

Authors:  Xiao-Tong Hu; Chao He
Journal:  Chin J Cancer       Date:  2011-11-04

6.  Candidate tumor suppressor B-cell translocation gene 3 impedes neoplastic progression by suppression of AKT.

Authors:  Y-C Cheng; P-H Chen; H-Y Chiang; C-S Suen; M-J Hwang; T-Y Lin; H-C Yang; W-C Lin; P-L Lai; S-Y Shieh
Journal:  Cell Death Dis       Date:  2015-01-08       Impact factor: 8.469

7.  Aberration methylation of miR-34b was involved in regulating vascular calcification by targeting Notch1.

Authors:  Xiao Lin; Fuxingzi Li; Feng Xu; Rong-Rong Cui; Dan Xiong; Jia-Yu Zhong; Ting Zhu; Su-Kang Shan; Feng Wu; Xu-Biao Xie; Xiao-Bo Liao; Ling-Qing Yuan
Journal:  Aging (Albany NY)       Date:  2019-05-25       Impact factor: 5.682

8.  The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma.

Authors:  Zhenbing Lv; Huichun Zou; Kaiwen Peng; Jianmei Wang; Yi Ding; Yuling Li; Xiaoli Ren; Feifei Wang; Rui Chang; Li Liang; Yanqing Ding
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

9.  Gene expression correlations in human cancer cell lines define molecular interaction networks for epithelial phenotype.

Authors:  Kurt W Kohn; Barry M Zeeberg; William C Reinhold; Yves Pommier
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

10.  BTG4 is A Novel p53 Target Gene That Inhibits Cell Growth and Induces Apoptosis.

Authors:  Na Zhang; Tinghui Jiang; Yitao Wang; Sen Wang; Lanyue Hu; Youquan Bu
Journal:  Genes (Basel)       Date:  2020-02-19       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.